SMi’s Highly Potent Active Pharmaceutical Ingredients 2018 Conference are Hosting 2 Workshops! Read more
FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy Read more